Literature DB >> 2989485

Synthesis of N2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (lisinopril).

M T Wu, A W Douglas, D L Ondeyka, L G Payne, T J Ikeler, H Joshua, A A Patchett.   

Abstract

The synthesis and some of the spectral properties of N2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (lisinopril, MK-521) are described. This compound inhibits angiotensin-converting enzyme with an IC50 of 1.2 X 10(-9) M.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989485     DOI: 10.1002/jps.2600740330

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Decision analysis applied to the selection of angiotensin-converting enzyme inhibitors.

Authors:  B Santos Ramos; M J Piña Vera; E Carvajal Gragera; M Atienza Fernández
Journal:  Pharm World Sci       Date:  1993-10-15

Review 2.  Prescribed drugs containing nitrogen heterocycles: an overview.

Authors:  Majid M Heravi; Vahideh Zadsirjan
Journal:  RSC Adv       Date:  2020-12-15       Impact factor: 4.036

3.  Synthesis and Characterization of Compounds Related to Lisinopril.

Authors:  Ambati V Raghava Reddy; Srinivas Garaga; Chandiran Takshinamoorthy; Andra Naidu; Ramesh Dandala
Journal:  Sci Pharm       Date:  2015-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.